Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D FROHLICH

Showing results (91-100 of 361) with videos related to

Pageof 37
Sort By:
Cardiorenal Medicine|July 22, 2015
Hyperuricemia: A Biomarker of Renal Hemodynamic ImpairmentDinko Susic, Edward D Frohlich
Heart Disease and Stroke : a Journal for Primary Care Physicians|July 1, 1992
Hypertension due to renal arterial diseaseD Aristizabal, E D Frohlich
Journal of Chronic Diseases|January 1, 1982
Effects of weight reduction on arterial pressureE Reisin, E D Frohlich
Heart Failure Clinics|November 24, 2011
Pressure overloadEdward D Frohlich, Dinko Susic
Current Opinion in Lipidology|November 30, 2011
Salt consumption and cardiovascular, renal, and hypertensive diseases: clinical and mechanistic aspectsDinko Susic, Edward D Frohlich
Current Opinion in Cardiology|August 12, 2005
Sodium directly impairs target organ function in hypertensionEdward D Frohlich, Jasmina Varagic
American Heart Journal|April 1, 1975
A comparison of timolol and propranolol in essential hypertensionG Lohmöller, E D Frohlich
Journal of the American Society of Hypertension : JASH|April 15, 2014
Telmisartan improves survival and ventricular function in SHR rats with extensive cardiovascular damage induced by dietary salt excessDinko Susic, Edward D Frohlich
Journal of Hypertension|October 31, 1998
Nephroprotective effect of antihypertensive drugs in essential hypertensionD Susic, E D Frohlich
Pharmacotherapy|November 1, 1981
Pharmacokinetics, mechanisms of action, indications, and adverse effects of timolol maleate, a nonselective beta-adrenoreceptor blocking agentF G Dunn, E D Frohlich
Pageof 37

Showing results (91-100 of 361) with videos related to

Sort By:
Pageof 37
Cardiorenal Medicine|July 22, 2015
Hyperuricemia: A Biomarker of Renal Hemodynamic ImpairmentDinko Susic, Edward D Frohlich
Heart Disease and Stroke : a Journal for Primary Care Physicians|July 1, 1992
Hypertension due to renal arterial diseaseD Aristizabal, E D Frohlich
Journal of Chronic Diseases|January 1, 1982
Effects of weight reduction on arterial pressureE Reisin, E D Frohlich
Heart Failure Clinics|November 24, 2011
Pressure overloadEdward D Frohlich, Dinko Susic
Current Opinion in Lipidology|November 30, 2011
Salt consumption and cardiovascular, renal, and hypertensive diseases: clinical and mechanistic aspectsDinko Susic, Edward D Frohlich
Current Opinion in Cardiology|August 12, 2005
Sodium directly impairs target organ function in hypertensionEdward D Frohlich, Jasmina Varagic
American Heart Journal|April 1, 1975
A comparison of timolol and propranolol in essential hypertensionG Lohmöller, E D Frohlich
Journal of the American Society of Hypertension : JASH|April 15, 2014
Telmisartan improves survival and ventricular function in SHR rats with extensive cardiovascular damage induced by dietary salt excessDinko Susic, Edward D Frohlich
Journal of Hypertension|October 31, 1998
Nephroprotective effect of antihypertensive drugs in essential hypertensionD Susic, E D Frohlich
Pharmacotherapy|November 1, 1981
Pharmacokinetics, mechanisms of action, indications, and adverse effects of timolol maleate, a nonselective beta-adrenoreceptor blocking agentF G Dunn, E D Frohlich
Pageof 37